Fellowship · La Jolla, CA
Sponsored by Scripps Clinic/Scripps Green Hospital
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study.
Journal of hepatology · 2025 · 126 citations · Julio Gutierrez
Matrix-producing neutrophils populate and shield the skin.
Nature · 2025 · 68 citations · Kevin Kim
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022 · 151 citations · Fouad Moawad
Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.
Gastrointestinal endoscopy · 2022 · 106 citations · Fouad Moawad
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
Gastroenterology · 2021 · 190 citations · Julio Gutierrez
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
Gastroenterology · 2022 · 95 citations · Fouad Moawad
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
The Journal of allergy and clinical immunology · 2022 · 76 citations · Fouad Moawad
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.
Lancet (London, England) · 2025 · 24 citations · Julio Gutierrez